hepatocellular
carcinoma
hcc
consid
frequent
tumor
associ
high
mortal
rate
sever
risk
factor
contribut
pathogenesi
hcc
chronic
persist
infect
hepat
c
viru
hepat
b
viru
chronic
untreat
inflamm
liver
differ
etiolog
oxid
stress
fatti
liver
diseas
sever
treatment
protocol
use
treatment
hcc
also
associ
divers
side
effect
mani
natur
product
help
cotreat
prevent
hcc
sever
mechan
involv
action
herbal
product
bioactiv
compound
prevent
cotreat
hcc
inhibit
liver
cancer
develop
progress
sever
way
protect
liver
carcinogen
enhanc
effect
chemotherapeut
drug
inhibit
tumor
cell
growth
metastasi
suppress
oxid
stress
chronic
inflamm
review
discuss
util
divers
natur
product
prevent
cotreat
hcc
captur
common
risk
factor
known
lead
hcc
shed
light
possibl
mechan
action
theori
assum
shut
risk
factor
cancer
develop
pathway
critic
strategi
cancer
prevent
manag
recommend
use
plant
side
side
recent
chemic
medic
stop
chemic
mainten
therapi
avoid
hcc
progress
decreas
global
incid
nonalcohol
fatti
liver
diseas
nafld
altern
nonalcohol
steatohepat
nash
condit
liver
patholog
http
doi
mortal
rate
due
hepatocellular
carcinoma
hcc
increas
rapidli
past
decad
unluckili
clinic
satisfactori
success
treatment
hcc
patient
still
absent
sever
risk
factor
involv
hepatocarcinogenesi
like
nonalcohol
fatti
liver
diseas
nafld
hepat
b
viru
hbv
hepat
c
viru
hcv
infect
alcohol
obes
aflatoxin
iron
accumul
diabet
sever
protocol
use
treatment
hcc
includ
surgic
resect
ablat
chemotherapi
embol
use
method
limit
due
side
effect
develop
resist
avail
chemotherapi
complex
due
limit
treatment
option
hcc
surgeri
poor
prognosi
diseas
critic
need
addit
therapi
enhanc
surviv
qualiti
life
complementari
altern
medicin
cam
consid
one
way
may
improv
anticanc
drug
efficaci
reduc
toxic
effect
use
herbal
medicin
trace
back
year
ago
ancient
china
egypt
recent
decad
increas
number
herbal
product
includ
medicin
herb
phytochem
use
treat
chronic
liver
diseas
worldwid
due
cost
effect
higher
safeti
margin
longlast
cur
effect
advers
effect
accord
previou
studi
medicin
herb
phytochem
could
protect
liver
sever
mechan
elimin
viru
block
fibrogenesi
inhibit
oxid
injuri
suppress
tumorigenesi
review
discuss
sever
factor
lead
hcc
develop
focus
role
differ
herbal
medicin
use
treatment
hcc
allevi
risk
factor
similar
fatti
liver
damag
caus
alcohol
happen
nonalcohol
abus
peopl
nafld
character
accumul
triglycerid
within
hepatocyt
usual
associ
metabol
syndrom
obes
preval
nafld
establish
histolog
featur
found
obes
individu
suffer
steatosi
steatosi
present
lean
individu
nafld
also
present
obes
individu
lean
fatti
liver
also
found
lean
nonalcohol
individu
sever
studi
base
ultrasound
imag
nafld
present
adult
individu
children
western
world
nafld
consid
one
import
reason
lead
chronic
liver
diseas
hong
kong
china
highfat
content
modern
diet
individu
lifestyl
nafld
consid
one
import
reason
caus
chronic
liver
diseas
develop
develop
countri
nafld
increas
risk
hepatocarcinogenesi
similar
pot
cirrhot
liver
diseas
hcc
end
stage
lead
caus
obesityrel
cancer
death
middleag
men
usa
increas
number
case
report
show
hcc
aris
noncirrhot
individu
suffer
nafld
hcc
risk
factor
may
synergist
involv
hcc
develop
besid
nafld
alcohol
liver
injuri
chronic
hepat
c
sever
mechan
involv
nafldrel
hcc
develop
fig
obes
particip
increas
risk
cancer
develop
lowgrad
chronic
inflammatori
impact
expans
adipos
tissu
stimul
gener
proinflammatori
cytokin
tumor
necrosi
factor
tnf
tnf
deriv
adipos
tissu
play
import
role
hcc
develop
role
support
experiment
model
assum
obes
enhanc
growth
diethylnitrosamineinduc
malign
liver
tumor
mice
preval
hcc
due
nafld
increas
around
world
hcc
patient
western
countri
attribut
nafld
asia
viral
hepat
remain
endem
hcc
patient
attribut
nafld
wolfberri
famou
tradit
chines
supplement
drug
fruit
part
lycium
barbarum
plant
famili
solanacea
valuabl
benfit
eye
liver
import
part
wolfberri
lycium
polysaccharid
portion
lpp
numer
biolog
action
like
immunoregul
antioxid
effect
neuroprotect
control
glucos
metabol
antitumor
activ
lymphocyt
number
immunoglobulin
g
level
found
increas
upon
intak
polysaccharid
juic
human
be
one
clinic
trial
report
also
increas
level
serum
antioxid
decreas
lipid
peroxid
level
liver
lpp
found
inhibit
hepatocyt
prolifer
induc
apoptosi
hepatoma
cell
indic
possibl
applic
antitumor
anoth
studi
demonstr
lpp
caus
restor
activ
antioxid
enzym
reduct
oxid
stress
product
caus
highfat
diet
induc
liver
injuri
cotreat
lpp
ethanol
administr
markedli
enhanc
liver
injuri
alcoholinduc
liver
injuri
rat
model
decreas
oxid
stress
accumul
lipid
liver
acut
liver
injuri
lpp
found
keep
normal
hepat
histolog
decreas
hepat
inflammationchemoattract
stimul
partial
regener
liver
nuclear
factor
kappa
b
depend
pathway
reduc
oxid
stress
use
prior
ccl
intox
mice
lpp
help
nafld
due
use
properti
decreas
inflamm
oxid
stress
cotreat
lpp
oral
nafld
rat
show
signific
improv
hepat
histolog
reduct
fibrosi
oxid
stress
inflamm
accumul
fat
apoptosi
modul
transcript
factor
activ
furthermor
uptak
lpp
longterm
unwant
side
effect
liver
healthi
rat
lpp
use
nafld
treatment
minim
side
effect
green
tea
camellia
sinensi
leav
report
use
prevent
liver
diseas
origin
green
tea
china
distribut
asian
countri
includ
korea
vietnam
japan
last
year
green
tea
also
spread
western
countri
tradit
consum
black
tea
benefici
therapeut
properti
green
tea
extract
report
sever
studi
major
polyphenol
green
tea
egcg
use
ccl
treat
mice
show
signific
therapeut
potenti
hepat
damag
inflamm
oxid
stress
induc
ccl
dosedepend
manner
biochem
histolog
level
also
report
cotreat
whole
green
tea
extract
alcohol
administr
show
effect
reduct
hepat
oxid
stress
reduc
form
nicotinamid
adenin
dinucleotid
phosphat
nadph
oxidas
system
experiment
alcoholinduc
liver
injuri
green
tea
extract
also
show
enhanc
nash
featur
oxid
stress
inflamm
lipid
accumul
obes
mice
recent
studi
also
demonstr
green
tea
extract
show
signific
improv
inflammatori
chemic
metabol
radiolog
paramet
nafld
patient
dyslipidem
nondiabet
also
show
improv
liver
enzym
nafld
patient
anoth
studi
numer
vitro
studi
demonstr
chemoprevent
antitumor
properti
green
tea
hcc
growth
cell
prolifer
hccderiv
cell
inhibit
egcg
induct
apoptosi
human
hcc
cell
line
growth
also
inhibit
egcg
suppress
phosphoryl
insulinlik
growth
receptor
reduc
activ
signal
molecul
like
extracellular
signalregul
kinas
erk
akt
drink
egcg
caus
signific
inhibit
liver
cell
adenoma
develop
contrast
egcguntr
control
group
relat
decreas
phosphoryl
erk
akt
protein
activ
hepat
ampactiv
kinas
protein
treatment
liver
steatosi
administr
egcg
drink
water
also
caus
signific
reduct
serum
level
insulin
tumor
necrosi
factor
tnf
free
fatti
acid
also
caus
decreas
hepat
express
interleukin
mrna
develop
glutathion
stransferas
placent
form
gstp
foci
also
inhibit
administr
egcg
drink
water
reduct
hepat
fibrosi
triglycerid
content
inflamm
oxid
stress
inhibit
excess
hepatocyt
prolifer
resveratrol
rsv
phytoalexin
extract
red
grape
consid
one
accept
recogn
herbal
deriv
worldwid
power
antioxid
antiinflammatori
properti
recent
rsv
found
help
treatment
nafld
rsv
given
nafld
induct
use
high
fatdiet
caus
reduct
lipogen
gene
fa
treatment
rsv
also
reduc
inflamm
oxid
stress
rat
rsv
caus
dysregul
metabol
lipid
nafld
sirtuin
pathway
upregul
hepat
lowdens
lipoprotein
receptor
rsv
increas
apoptosi
hcc
cell
associ
reduct
hexokinas
express
addit
rsv
improv
inhibit
cell
growth
induc
sorafenib
aerob
glycolyt
hcc
cell
inhibit
hexokinas
rsv
consid
new
trend
treat
hcc
prevent
progress
rsv
also
found
decreas
express
myosin
light
chain
kinas
mlck
inhibit
liver
tumorigenesi
promot
cell
apoptosi
hcc
rat
induc
dena
express
mlck
found
higher
hcc
rat
normal
rat
respons
prolifer
antiapoptot
properti
latin
word
inflamm
mean
set
light
ignit
describ
exactli
effect
cancer
inflamm
increas
resist
chemotherapi
promot
oncogen
gene
convert
healthi
cell
tumor
also
stimul
cancer
cell
spread
improv
cancer
cell
abil
angiogenesi
cancer
defin
inflamm
antiinflammatori
drug
use
treat
cancer
relat
cancer
develop
inflamm
appreci
hepat
damag
may
due
either
chronic
acut
inflamm
respons
inflamm
sever
kind
hepat
cell
activ
hepat
stellat
cell
hsc
liver
sinusoid
endotheli
cell
lsec
kupffer
cell
kc
dendrit
cell
dc
produc
sever
type
cytokin
immun
mediat
chemokin
one
import
proinflammatori
cytokin
inhibit
apoptosi
tissu
inflamm
inflammatori
respons
mediat
defens
mechan
microbi
infect
stimul
tissu
regener
repair
relat
inflamm
cancer
develop
chronic
inflamm
stimul
develop
dysplasia
cancer
occurr
associ
microbi
infect
immunocompet
patient
chronic
inflamm
like
hepat
b
c
viral
infect
human
papilloma
viru
may
result
develop
hepatocellular
cervic
carcinoma
respect
cancer
also
may
result
opportunist
infect
like
kaposi
sarcoma
result
human
herp
viru
hhv
infect
inappropri
immun
respons
microb
may
also
lead
cancer
develop
gastric
cancer
may
result
chronic
inflamm
due
helicobact
pylori
colon
longstand
inflammatori
bowel
diseas
may
lead
colon
cancer
longterm
exposur
asbesto
silica
cigarett
smoke
may
lead
chronic
irrit
subsequ
inflamm
result
cancer
develop
promot
tumor
cell
requir
surviv
initi
cell
expans
numer
inflammatori
mediat
like
chemokin
eicanosoid
cytokin
abil
stimul
prolifer
untransform
tumor
cell
inflamm
play
import
role
tumor
growth
angiogenesi
mediat
also
play
critic
role
aspect
tumor
progress
like
metastasi
tissu
invas
matrix
metalloproteinas
inhibitor
import
remodel
extracellular
matrix
angiogenesi
enhanc
vascular
invas
migrat
cell
mechan
contribut
role
inflamm
hepatocarcinogenesi
show
fig
xanthorrhizol
xnt
sesquiterpenoid
complex
obtain
curcuma
xanthorrhizza
rhizom
famili
zingiberacea
antiinflammatori
effect
xnt
report
first
time
lipopolysaccharidemedi
mous
leukem
monocyt
macrophag
cell
raw
caus
signific
reduct
activ
induc
nitric
oxid
synthas
ino
reduc
inhibit
nitric
oxid
prostaglandin
pge
product
xnt
also
found
inhibit
proinflammatori
cytokin
ino
activ
microgli
cell
antiinflammatori
properti
xnt
also
postul
anoth
studi
block
inflammatori
neurogen
pain
respons
pain
test
induc
formalin
rat
xnt
also
anticanc
activ
may
due
antiinflammatori
effect
inhibit
activ
nfkb
ino
releas
also
inhibit
tumor
develop
format
differ
vivo
studi
decreas
express
ornithin
decarboxylas
suppress
nfkb
signal
activ
vivo
studi
also
demonstr
xanthorrhizol
antimetastat
activ
inhibit
matrix
metallopeptidas
mice
lung
metastasi
model
potent
antiprolif
effect
cell
apoptosi
induct
via
famili
member
berberin
small
alkaloid
molecul
isol
coptidi
rhizom
possess
antiinflammatori
anticanc
activ
downregul
numer
hepat
proinflammatori
gene
serum
amyloid
nfkb
gene
play
vital
role
steatohepat
develop
report
berberin
antiinflammatori
activ
hepat
cell
differ
anim
model
also
show
decreas
express
cyclophosphamideinduc
hepatotox
rat
model
also
abil
inhibit
product
cell
antiinflammatori
effect
berberin
may
due
inhibit
activ
antiinflammatori
effect
postul
inhibit
lpsinduc
inflammatori
respons
macrophag
berberin
anticanc
activ
human
hcc
cell
line
induct
apoptosi
inhibit
tumor
cell
prolifer
berberin
induc
cell
death
apoptosi
cell
relat
downregul
highli
express
hcc
cell
shown
select
inhibit
human
hepatocellular
cancer
cell
growth
induct
ampkmedi
caspasedepend
mitochondri
pathway
cell
apoptosi
addit
suppress
express
found
upregul
berberin
suppress
inner
inhibitor
posttranscript
level
combin
berberin
vincristin
show
help
effect
hepatoma
cell
line
potenti
proapoptot
effect
singl
drug
alpinia
officinarum
known
lesser
galang
belong
famili
zingiberacea
varieti
pharmacolog
action
antioxid
antiinflammatori
antimicrobi
antiemet
cytotox
properti
differ
mechan
involv
antiinflammatori
effect
alpinia
officinarum
includ
regul
mapk
pathway
inhibit
prostaglandin
synthas
import
enzym
involv
inflamm
effect
usual
due
content
diarylheptanoid
flavonoid
two
compound
alpinia
officinarum
rhizom
extract
galangin
exhibit
antioxid
antiinflammatori
activ
due
phenol
content
compound
show
high
affin
toward
activ
site
molecular
dock
studi
recent
studi
also
demonstr
five
compound
isol
alpinia
officinarum
rhizom
extract
show
power
antiinflammatori
effect
cell
stimul
lipopolysaccharid
compound
galangin
isorhamnetin
two
diarylheptanoid
kaempferid
compound
downregul
gene
express
proinflammatori
cytokin
dosedepend
manner
indic
isol
compound
may
promis
treatment
inflammatori
diseas
alpinia
officinarum
rhizom
extract
compon
show
anticanc
activ
numer
cancer
cell
line
breast
neuroblastoma
lung
liver
previou
studi
suggest
alpinia
officinarum
rhizom
extract
use
promis
natur
chemoprevent
agent
hcc
rat
also
help
chemosensit
agent
use
combin
cisplatin
treatment
hcc
addit
alpinia
officinarum
rhizom
extract
improv
hepat
function
decreas
alphafetoprotein
concentr
experiment
hcc
model
also
protect
hepat
tissu
treat
rat
oxid
stress
os
occur
bodi
expos
either
harm
exogen
endogen
peroxid
stimuli
one
stimuli
free
radic
includ
reactiv
nitrogen
speci
rn
reactiv
oxygen
speci
ro
free
radic
produc
numer
oxidationreduct
redox
reaction
happen
cell
os
usual
associ
develop
variou
diseas
cardiovascular
nervou
system
diseas
diabet
cancer
induct
oxid
damag
dna
abnorm
express
protein
os
may
risk
factor
hcc
elev
hepatocyt
dna
oxid
damag
chronic
viral
infect
may
increas
product
ro
rn
caus
inflamm
necrosi
hepatocyt
accompani
immun
cell
infiltr
main
caus
dna
damag
mutat
caus
increas
ro
failur
dna
repair
result
increas
mutat
cancerrel
gene
mean
chronic
inflamm
consid
main
risk
factor
hcc
increas
os
degre
dna
damag
elev
incid
hcc
relat
viral
infect
elev
level
transform
growth
factor
beta
also
patient
chronic
hepat
c
mainli
relat
oxid
stress
use
indic
tissu
damag
extent
injur
ro
elev
due
increas
oxid
stress
stop
electron
transport
chain
damag
mitochondria
excess
releas
caus
sever
damag
mitochondri
respiratori
chain
also
caus
damag
cytochrom
oxidas
high
level
ro
increas
lipid
peroxid
inhibit
respiratori
electron
transport
chain
ro
alter
mitochondri
metabol
activ
also
affect
apoptot
pathway
chang
membran
permeabl
caus
damag
mitochondri
dna
telomer
shorten
acceler
os
lead
increas
cytoplasm
migrat
revers
transcriptas
telomeras
subunit
damag
cell
mainli
os
caus
releas
uniqu
type
dna
call
free
circul
dna
fcdna
produc
oxid
releas
dna
dead
cell
use
indic
wide
group
diseas
like
cancer
fc
dna
also
present
low
valu
normal
cell
exposur
os
differ
type
gene
immun
system
mediat
express
alter
among
mediat
micro
rna
mirna
small
noncod
rna
molecul
contain
nucleotid
found
plant
anim
virus
function
rna
silenc
posttranscript
regul
gene
express
mirna
dysfunct
relat
differ
type
cancer
includ
hcc
mechan
hcc
develop
caus
os
summar
fig
vitamin
c
diallyl
sulfid
vitamin
c
lascorb
lascorb
acid
known
antioxid
activ
abil
captur
free
radic
singlet
oxygen
oh
hoo
superoxid
ion
produc
dehydroascorb
vitamin
c
activ
relat
free
electron
interact
electron
defici
ion
sever
vitro
studi
report
antioxid
activ
vitamin
c
vivo
studi
also
show
antioxid
properti
vitamin
c
dosedepend
manner
vitamin
c
administr
protect
guinea
pig
form
vitamin
c
osteodystrophi
syndrom
rat
oxid
stress
given
oxid
agent
endotoxin
carbon
tetrachlorid
also
protect
rat
expos
cigarett
smoke
parquet
highli
toxic
nitrogen
herbicid
strong
oxid
stress
administr
vitamin
c
reduc
oxid
stress
parquet
administr
vitamin
c
promis
role
cancer
treatment
select
cytotox
activ
divers
cancer
cell
line
clinic
studi
perform
prove
ascorb
import
role
increas
surviv
cancer
patient
late
stage
combin
methotrex
vitamin
c
promis
cancer
treatment
reduct
h
produc
methotrex
cell
shown
vitamin
c
help
treatment
hepatotox
induc
dena
ko
mice
garlic
contain
diallyl
sulfid
da
major
activ
constitu
da
character
antiinflammatori
activ
modul
cytokin
inhibit
activ
nfkb
da
antiinflammatori
activ
relat
nuclear
factor
erythroid
factor
transcript
activ
also
antioxid
activ
emerg
regul
cellular
resist
oxid
combin
vitamin
c
da
shown
offer
sever
benefit
inhibit
circulatori
denainduc
hcc
rat
increas
sensit
chemotherapi
cisplatin
treatment
hcc
ginger
zingib
officinal
one
predomin
herbac
plant
perenni
plant
main
activ
part
rhizom
ginger
use
condiment
also
antiemet
anticanc
activ
ginger
strong
antioxid
cell
protect
activ
action
ginger
due
potent
activ
constitu
sesquiterpenoid
tannin
gingerol
shogaol
anthocyanin
sever
vitro
vivo
studi
document
antioxid
activ
ginger
protect
effect
ginger
show
sever
toxic
agent
like
bromobenzen
cisplatin
anoth
studi
display
chemoprevent
effect
ginger
cancer
ginger
great
activ
treatment
experiment
cancer
rat
model
decreas
level
growth
factor
liver
tumor
marker
give
rat
daili
dose
mgkg
ginger
extract
anticanc
effect
ginger
due
proapoptot
antiinflammatori
properti
antiinflammatori
activ
ginger
confirm
inhibit
administr
mgkg
ginger
hcc
rat
model
ginger
contain
differ
constitu
clavatol
pinostrobin
geraniol
activ
compon
detect
ga
chromatographi
mass
spectrometri
ginger
found
inhibit
prolifer
cell
cell
line
one
popular
activ
compon
ginger
show
anticanc
effect
hepatoma
cell
line
activ
rosmedi
caspasedepend
apoptosi
multidrug
resist
one
popular
cultiv
plant
broccoli
distinguish
high
content
antioxid
content
activ
antioxid
compon
plant
vitamin
flavonoid
carotenoid
isothiocyan
hydrolyt
product
glucosinol
consid
one
antioxid
compon
motiv
dna
protect
damag
antioxid
activ
antioxid
properti
broccoli
may
direct
contribut
biochem
cellular
physiolog
step
inhibit
free
radic
product
indirect
induc
phase
ii
enzym
protect
effect
os
antioxid
activ
broccoli
observ
human
colon
mucosa
expos
oxid
stress
broccoli
show
potenti
anticanc
activ
due
high
content
glucosinol
broccoli
also
contain
distinct
compon
sulforaphan
character
activ
antioxid
abil
protect
dna
break
highli
reactiv
electrophil
increas
antioxid
system
activ
inhibit
inflamm
antioxid
activ
sulforaphan
relat
certain
pathway
includ
reduct
inflamm
inhibit
overexpress
transcript
import
role
keep
healthi
cell
protect
toxic
chemic
lifestylerel
factor
previou
vivo
studi
regist
sulforaphan
abroad
activ
differ
type
liver
diseas
relat
toxic
chemic
consumpt
alcohol
use
high
calori
food
broccoli
major
role
suppress
differ
type
cancer
includ
liver
colon
cancer
sulforaphan
differ
pathway
relat
anticanc
effect
antiinflammatori
proapoptot
cell
cycl
arrest
action
hbv
hcv
infect
consid
chief
reason
hcc
usual
symptom
peopl
chronic
infect
late
cirrhosi
hcc
develop
treat
overcom
hcv
hbv
infect
help
prevent
hcc
develop
oncogen
virus
associ
hcv
infect
hcc
vari
worldwid
western
countri
africa
hcv
consid
main
caus
hcc
also
contribut
hcc
case
japan
well
patient
infect
hcv
progress
chronic
hepat
develop
cirrhosi
hcv
relat
liver
cirrhosi
increas
risk
liver
cancer
higher
risk
develop
hcc
chronic
hepat
c
infect
alon
although
risk
differ
depend
degre
liver
fibrosi
caus
hcv
elev
risk
hcc
develop
patient
infect
hcv
aris
chronic
inflamm
result
progress
liver
fibrosi
cirrhosi
inflamm
caus
alter
architectur
hepatocyt
defect
cellular
function
microcircul
liver
hcv
rna
integr
host
genom
altern
hcv
viral
protein
like
hcv
core
protein
induc
host
respons
involv
reactiv
oxygen
speci
ro
product
apoptosi
activ
transcript
modul
immun
upregul
particip
transform
malign
hepat
b
viru
hbv
circular
genom
chronic
hbv
infect
confirm
presenc
serum
hbsag
period
less
month
hepat
b
patient
high
risk
hcc
develop
life
chronic
hepat
differ
caus
hcc
hcc
occur
absenc
cirrhosi
tobacco
smoke
hbv
consid
second
environment
carcinogen
affect
individu
result
hcc
case
around
world
associ
chronic
hbv
infect
hcc
wide
recogn
first
explain
beasley
colleagu
taiwanes
patient
posit
serum
hb
surfac
antigen
hbsag
serum
hbsag
detect
patient
hcc
japan
patient
hcc
unit
state
patient
hcc
china
absenc
risk
factor
hbv
arriv
liver
cell
transcript
messeng
viral
rna
occur
follow
translat
viral
protein
synthesi
dna
viru
dna
viru
capabl
integr
host
genom
infect
hepatocyt
cancer
facilit
via
process
numer
way
like
rapid
cell
cycl
hepatocyt
viral
dna
integr
host
genom
caus
instabl
may
insert
adjac
gene
code
protein
requir
cancer
develop
also
lead
chronic
inflamm
fibrosi
prolifer
hepatocyt
ultim
result
cirrhosi
cancer
develop
andrographi
paniculata
nee
paniculata
medicin
plant
belong
famili
acanthacea
use
japan
india
korea
china
asian
countri
long
time
treatment
sever
diseas
like
inflamm
viral
bacteri
infect
high
blood
pressur
abund
diterpen
lacton
found
leav
stem
paniculata
andrographolid
andrographolid
treatment
found
reduc
replic
hcv
markedli
synergist
effect
clinic
trial
drug
current
antivir
drug
like
telaprevir
use
combin
treat
hcv
mechan
action
andrographolid
fig
mechan
hcc
develop
due
oxid
stress
may
due
abil
induc
pathway
mapk
stand
mitogen
activ
protein
kinas
heme
shown
andrographolid
use
natur
product
potenti
drug
help
treatment
hcv
treatment
paniculata
aqueou
extract
found
enhanc
activ
hepat
enzym
normal
histopatholog
chang
malign
hepat
tissu
induc
hexachlorocyclohexan
show
indirect
direct
effect
tumor
cell
induc
apoptosi
cancer
cell
necrosi
improv
bodi
immun
system
tumor
cell
inhibit
cellcycl
arrest
cancer
cell
prolifer
ethanol
extract
paniculata
show
cytotox
effect
divers
human
cancer
cell
line
like
prostat
hepatoma
colon
colon
cancer
cell
jurkat
lymphocyt
inhibitori
effect
andrographolid
analog
tumor
cell
may
due
abil
depress
cyclindepend
kinas
induc
express
inhibitori
protein
cell
cycl
result
block
cell
cycl
progress
andrographolid
caus
induct
apoptosi
sever
mechan
includ
activ
caspas
cascad
releas
cytochrom
c
mitochondria
activ
proapoptot
famili
member
bax
conform
chang
also
caus
activ
rosdepend
cjun
nh
termin
kinas
jnk
result
activ
tumor
suppressor
therebi
increas
phosphoryl
protein
stabil
silymarin
extract
milk
thistl
seed
silybum
marianum
l
gaertn
belong
asteracea
famili
extract
silymarin
contain
silibinin
consist
mixtur
two
flavonolignan
call
silybin
sa
silybin
b
sb
divers
pharmacolog
activ
includ
antioxid
antiprolif
immunomodulatori
antivir
activ
antifibrot
differ
tissu
organ
silymarin
compon
silibinin
possess
antivir
activ
hcv
infect
cell
cultur
antivir
activ
due
abil
block
entri
viru
synthesi
viral
rna
protein
viral
fusion
viru
transmiss
activ
hcv
rna
depend
rna
polymeras
one
studi
show
treatment
solubl
form
silibinin
form
daili
intraven
inject
caus
signific
inhibit
hcv
viral
load
log
week
previou
ifn
nonrespond
patient
sever
studi
report
silymarin
potenti
anticanc
effect
hcc
dosedepend
manner
silymarin
inhibit
popul
growth
human
hepatocellular
cancer
cell
elev
percentag
apoptot
cell
antiprolif
activ
silymarin
also
report
anoth
studi
without
affect
nontumor
hepat
cell
phase
silymarin
caus
increas
percentag
cell
sphase
decreas
cell
percentag
associ
downregul
cyclin
e
cyclin
phosphorb
upregul
retinoblastoma
protein
rb
silymarin
also
show
vivo
prevent
therapeut
effici
liver
cancer
ramakrishnan
et
al
report
silymarin
protect
effect
denainduc
hcc
rat
silymarin
also
show
potent
prevent
effect
spontan
hcc
hbv
x
protein
transgen
mous
model
oral
silymarin
doserespons
manner
caus
restor
earli
stage
hepat
damag
fatti
chang
lead
recoveri
hepat
tissu
oral
administr
silibinin
show
signific
reduct
hcc
xenograft
growth
induc
histon
acetyl
apoptosi
express
inhibit
cell
cycl
progress
cell
prolifer
express
erk
ptenpakt
signal
glycyrrhiza
glabra
perenni
herb
origin
southwestern
central
asia
mediterranean
region
show
numer
pharmacolog
activ
like
antioxid
antiinflammatori
immunomodulatori
activ
main
constitu
glycyrrhiza
glabra
root
glycyrrhizin
ww
glycyrrhizin
antivir
antiinflammatori
hepatoprotect
antitumor
activ
antivir
activ
report
glycyrrhizin
compon
isol
glycyrrhiza
speci
differ
virus
herp
simplex
hiv
sever
acut
respiratori
syndrom
influenza
viru
coronaviru
enterovirus
hepat
virus
glycyrrhizin
report
use
treatment
hepat
diseas
like
chronic
hepat
c
b
prepar
contain
glycyrrhizin
report
reduc
hepat
steatosi
transgen
mice
express
fulllength
hcv
polyprotein
shown
inhibitori
effect
hcv
core
gene
express
hcv
fulllength
viral
particl
protein
rna
level
synergist
effect
interferon
glycyrrhizin
compon
glycyrrhiza
glabra
show
antitumor
activ
differ
kind
cancer
skin
liver
breast
cancer
inhibit
cellular
prolifer
develop
growth
cancer
cell
glycyrrhiz
acid
major
bioactiv
compon
extract
glycyrrhiza
glabra
abil
inhibit
hcc
occurr
denatr
mice
anoth
studi
show
glycyrrhiza
glabra
extract
potent
effect
treatment
hcc
induc
rat
effect
potent
effect
cisplatin
alon
cisplatin
combin
glycyrrhiza
glabra
cisplatin
sever
side
effect
glycyrrhiza
glabra
associ
side
effect
apoptosi
program
cell
death
great
interest
field
oncolog
recognit
pathway
apoptosi
import
understand
cancer
develop
also
prevent
treatment
diseas
normal
tissu
homeostasi
maintain
keep
balanc
prolifer
cell
death
imbal
two
process
may
lead
dysregul
clonal
expans
caus
neoplast
diseas
mechan
action
numer
cytotox
agent
includ
apoptosi
sever
experiment
approach
aim
stimul
apoptosi
lead
improv
therapeut
respons
numer
natur
product
play
vital
role
regul
cellular
prolifer
differenti
chemoprevent
chemotherapeut
activ
natur
product
may
due
role
mediat
differ
pathway
involv
cancer
develop
progress
herbal
cytotox
activ
nigella
sativa
nigella
sativa
n
sativa
annual
flower
plant
origin
south
southwest
asia
northern
africa
grown
almost
world
n
sativa
main
constitu
thymoquinon
tq
possess
numer
therapeut
pharmacolog
activ
like
antiinflammatori
anticanc
antioxid
immunomodulatori
activ
cytotox
activ
ethyl
acet
column
chromatograph
fraction
ethanol
extract
n
sativa
show
cytotox
effect
divers
cell
line
hep
anoth
vitro
studi
show
cytotox
crude
methanol
extract
n
sativa
dalton
lymphoma
ascit
dla
ehrlich
ascit
carcinoma
eac
cell
cell
anticanc
activ
due
abil
exhibit
power
proapoptot
antiprolif
antimutagen
antimetastat
antioxid
effect
also
inhibit
tumor
initi
progress
antiinflammatori
immunomodulatori
effect
n
sativa
regul
signal
pathway
like
ino
caspas
antitumor
activ
n
sativa
report
sever
vivo
vitro
studi
decoct
consist
seed
n
sativa
smilax
glabra
rhizom
hemidesmu
indicu
root
show
signific
improv
hepatocarcinogenesi
induc
dena
gkgday
rat
ethanol
extract
n
sativa
show
mark
enhanc
denainduc
histopatholog
variat
hepat
tissu
anoth
vivo
studi
show
administr
methanol
extract
n
sativa
hcc
albino
rat
model
show
modul
glucoregulatori
enzym
aqueou
extract
n
sativa
show
vitro
antiprolif
activ
morpholog
chang
like
membran
damag
cell
shrinkag
cell
lead
dna
damag
cell
death
decreas
cell
prolifer
mechan
explain
pharmacolog
effect
nigella
sativa
summar
fig
illicium
verum
verum
hook
belong
famili
illiciacea
commonli
known
chines
star
anis
star
anis
aromat
evergreen
tree
origin
pakistan
china
asian
countri
due
low
toxic
effect
human
classifi
food
medicin
ministri
health
peopl
republ
china
main
activ
constitu
present
verum
sesquiterpenoid
monoterpenoid
lignan
phenylpropanoid
volatil
compound
flavonoid
also
contain
tannin
bitter
principl
essenti
oil
essenti
oil
includ
transanethol
limon
farnesol
safrol
also
possess
antimicrobi
antioxid
antifung
analges
antiinflammatori
sed
insecticid
anticonvuls
activ
cytotox
activ
also
report
sever
studi
show
numer
mechan
involv
cell
death
apoptosi
induct
scaveng
free
radic
tumor
metastasi
inhibit
report
alcohol
extract
verum
show
signific
vitro
antiprolif
activ
similar
vitro
studi
also
show
mark
inhibit
cell
prolifer
alcohol
extract
promot
apoptosi
growth
inhibit
modul
proapoptot
gene
express
like
bax
separ
cytotox
effect
verum
extract
studi
liver
cancer
model
exhibit
signific
anticanc
outcom
hepat
tissu
rat
signific
improv
tumor
burden
decreas
nodul
incid
multipl
size
volum
liver
weight
also
upregul
phase
ii
detoxifi
enzym
glutathionestransferas
decreas
oxid
stress
restor
superoxid
dismutas
activ
sex
vital
role
hcc
develop
male
diagnos
hcc
femal
ratio
may
due
higher
suscept
male
infect
viral
hepat
smoke
consum
higher
amount
alcohol
higher
bodi
mass
index
femal
higher
level
testosteron
associ
advanc
hepat
fibrosi
male
infect
hcv
hcc
hepat
b
carrier
anoth
potent
hepatocarcinogen
aflatoxin
produc
aspergillu
speci
found
corn
grain
soybean
peanut
store
warm
humid
condit
sever
genet
metabol
diseas
associ
hcc
develop
wilson
diseas
hemochromatosi
antitrypsin
diseas
glycogenstorag
diseas
type
ii
porphyria
tyrosinemia
factor
also
report
associ
mark
elev
hcc
develop
cigarett
smoke
prolong
use
contracept
pill
diabet
mellitu
consid
independ
risk
factor
hcc
caus
liver
cell
damag
hyperinsulinemia
insulin
resist
hyperinsulinemia
induc
hcc
inflamm
cellular
prolifer
apoptosi
inhibit
well
increas
insulin
level
lead
declin
synthesi
insulin
growth
factor
bind
protein
liver
suppos
caus
increas
bioavail
insulinlik
growth
factor
addit
fig
cellular
molecular
mechan
n
sativa
explain
proapoptot
antiprolif
cytotox
antioxid
antimetastat
antimutagen
nkmediat
effect
lsa
lipidbound
sialic
acid
tsa
total
sialic
acid
tumor
necrosi
factor
mda
malondialdehyd
afp
ro
reactiv
oxygen
speci
nitric
oxid
gsh
glutathion
tpa
tissuetyp
plasminogen
activ
upa
urokinasetyp
plasminogen
activ
plasminogen
activ
inhibitor
type
increas
apoptosi
inhibit
cellular
prolifer
insulin
also
relat
increas
oxid
stress
ro
product
particip
dna
mutat
effici
storag
cereal
liabl
aspergillu
attack
continu
inspect
male
femal
sex
hormon
suspect
individu
manag
storag
diseas
wilson
hemochromatosi
control
diabet
mellitu
lead
diseas
certainli
contribut
declin
hcc
liabil
among
riski
individu
plant
activ
mention
review
could
summar
tabl
hcc
preval
diseas
mani
countri
around
world
highli
relat
increas
death
rate
develop
hcc
pass
sever
intermedi
step
molecular
transcript
event
end
final
malign
transform
hepatocyt
sever
factor
involv
step
includ
nafld
hcv
hbv
oxid
stress
chronic
inflamm
inborn
metabol
error
environment
toxin
drug
etc
accumul
evid
suggest
mani
dietari
natur
product
could
potenti
sourc
prevent
treatment
liver
cancer
natur
product
summar
tabl
activ
ingredi
inhibit
liver
cancer
develop
progress
cut
road
front
known
lead
risk
factor
hcc
call
urg
ministri
health
countri
establish
record
liver
patient
especi
liver
tumor
recommend
use
plant
side
side
recent
chemic
medic
stop
chemic
mainten
therapi
avoid
hcc
progress
decreas
global
incid
also
draw
attent
specialist
food
industri
add
natur
product
differ
recip
reduc
probabl
liver
diseas
infect
none
none
antiinflammatori
antioxid
cytotox
immunomodulatori
illicium
verum
cytotox
activ
antioxid
antiinflammatori
induct
apoptosi
inhibit
tumor
metastasi
